Results

Total Results: over 10,000 records

Showing results for "analyzed".

301. Appendix-D-Surveillance-Report-1 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/appendix-d-surveillance-report-1.xlsx
     September 30, 2015 - Setting Country Eligibility criteria Interventions Sample Characteristics Screened Eligible Randomized Analyzed … B Screened: 88 Eligible: 30 Randomized: 30 Analyzed: 27 A vs. … Urine + for opiates: 63% Self-reported use of opiates: 89% Screened: 65 Eligible: 25 Randomized: 19 Analyzed … B Screened: 68 Eligible: 53 Randomized: 46 Analyzed: 40 (20 vs. 20) A vs. … Comparison Groups Population Characteristics Method For Assessing Outcomes and Confounders Enrolled Analyzed

302. App-D-Opioid-Chronic-Pain-Surveill-Report-1 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-opioid-chronic-pain-surveill-report-1.xlsx
     September 30, 2015 - Setting Country Eligibility Criteria Interventions Sample Characteristics Screened Eligible Randomized Analyzed … B Screened: 88 Eligible: 30 Randomized: 30 Analyzed: 27 A vs. … Urine + for opiates: 63% Self-reported use of opiates: 89% Screened: 65 Eligible: 25 Randomized: 19 Analyzed … B Screened: 68 Eligible: 53 Randomized: 46 Analyzed: 40 (20 vs. 20) A vs. … Comparison Groups Population Characteristics Method for Assessing Outcomes and Confounders Enrolled Analyzed

303. App-D-Opioid-Chronic-Pain-Surveill-Report-1 (xls file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/app-d-opioid-chronic-pain-surveill-report-1.xlsx
     September 30, 2015 - Setting Country Eligibility Criteria Interventions Sample Characteristics Screened Eligible Randomized Analyzed … B Screened: 88 Eligible: 30 Randomized: 30 Analyzed: 27 A vs. … Urine + for opiates: 63% Self-reported use of opiates: 89% Screened: 65 Eligible: 25 Randomized: 19 Analyzed … B Screened: 68 Eligible: 53 Randomized: 46 Analyzed: 40 (20 vs. 20) A vs. … Comparison Groups Population Characteristics Method for Assessing Outcomes and Confounders Enrolled Analyzed

304. SRDR - Systematic Review Data Repository |
     srdr.ahrq.gov/projects/1565/studies/189285
     January 01, 2018 - Point Measure No active treatment MAD Moderate OSA Severe OSA Baseline N/A N Analyzed … 29.5 26 32.1 6 months N Analyzed … Point Measure No active treatment MAD Moderate OSA Severe OSA Baseline N/A N Analyzed … 0.2 0.2 0.3 6 months N Analyzed

305. SRDR - Systematic Review Data Repository |
     srdr.ahrq.gov/projects/1312/studies/133119
     January 01, 2012 - Comments ( 0 ) | Post/View n Analyzed … All Participants Time Point Measure Exposure 1 Control 1 0 minutes N Analyzed … Mean SD SE 120 minutes N Analyzed

306. SRDR - Systematic Review Data Repository |
     srdr.ahrq.gov/projects/1312/studies/133148
     January 01, 2008 - Comments ( 0 ) | Post/View n Analyzed … Measure Exposure 1 Control 1 Exposure 2 Exposure 3 Control 2 0 hours N Analyzed … 3.6 4.8 SE 2 hours N Analyzed

307. SRDR - Systematic Review Data Repository |
     srdr.ahrq.gov/projects/1312/studies/133243
     January 01, 2013 - Comments ( 0 ) | Post/View n Analyzed … Time Point Measure Exposure 1 Exposure 2 Control 1 Exposure 3 0 days N Analyzed … .71 .42 SE 6 days N Analyzed

308. SRDR - Systematic Review Data Repository |
     srdr.ahrq.gov/projects/1312/studies/133242
     January 01, 2008 - Comments ( 0 ) | Post/View n Analyzed … Participants Time Point Measure Exposure 1 Exposure 2 Control 1 0 hours N Analyzed … .3 .3 SE 2 hours N Analyzed

309. SRDR - Systematic Review Data Repository |
     srdr.ahrq.gov/projects/1312/studies/147777
     January 01, 2016 - Comments ( 0 ) | Post/View n Analyzed … Exposure 1 Exposure 2 Exposure 3 Exposure 4 Exposure 5 Control 1 0 hours N Analyzed … 1.4 SE 8 hours N Analyzed

310. Building an Interoperable Regional Health Information Network Today with IHE Integration Profiles | AHRQ Digital Healthcare Research: Informing Improvement in Care Quality, Safety, and Efficiency
     digital.ahrq.gov/health-it-tools-and-resources/health-it-bibliography/health-information-exchange-hie/building
     Integrating the Healthcare Enterprise, a multi-national collaborative of care providers and developers that analyzed … supporting an interoperable RHIO solution among various EHR systems from more than 30 vendors will be analyzed

311. App-E-Surveillance-Report-1-Treatments-For-Acute-Pain (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-e-surveillance-report-1-treatments-for-acute-pain.xlsx
     December 22, 2021 - Compared Intervention Names and Doses Intervention Dose in Daily Morphine Equivalent N Randomized N Analyzed … Comparison Groups Population Characteristics Method for Assessing Outcomes and Confounders Enrolled Analyzed … Comparison Groups Population Characteristics Method for Assessing Outcomes and Confounders Enrolled Analyzed … Comparison Groups Population Characteristics Method for Assessing Outcomes and Confounders Enrolled Analyzed … Comparison Groups Population Characteristics Method for Assessing Outcomes and Confounders Enrolled Analyzed

312. SRDR - Systematic Review Data Repository |
     srdr.ahrq.gov/projects/1542/studies/186860
     January 01, 1998 - Triptans: None (before or during pregnancy) Not reported N/A N Analyzed … Triptans: None (before or during pregnancy) Delivery N/A N Analyzed 82 … Triptans: None (before or during pregnancy) Delivery N/A N Analyzed 82 … Triptans: None (before or during pregnancy) Delivery N/A N Analyzed 82 … Triptans: None (before or during pregnancy) Delivery N/A N Analyzed 96

313. NPSD Data Spotlight - Patient Safety and COVID-19: A Qualitative Analysis of Concerns During the Public Health Emergency (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/npsd/data/spotlights/spotlight-ptsafety-and-covid-19.pdf
     November 01, 2021 - • Among a sample of records analyzed, the most common description of the patient safety concern, … • Procedural issues with COVID-19 testing represented 13.0% of records analyzed. … Of the 320 records analyzed, 19 (5.9%) explicitly identified patients as having a negative COVID-19 … In total, approximately two-thirds of the records analyzed identified a patient safety concern due to … analyzed for contributing factors are not the same records.

314. Hierarchical Task Analysis | Digital Healthcare Research
     digital.ahrq.gov/health-it-tools-and-resources/evaluation-resources/workflow-assessment-health-it-toolkit/all-workflow-tools/hierarchical-task-analysis
     January 01, 2023 - DEFINE TASK BEING ANALYZED, as well as the purpose of the task analysis. 2. … Advantages Provides significant insight into the task being analyzed.

315. SRDR - Systematic Review Data Repository |
     srdr.ahrq.gov/projects/1520/studies/186803
     January 01, 2017 - Placebo 48 weeks N Analyzed 165 168 P-Value 0.226 … Placebo 48 weeks N Analyzed 165 168 Hazard Ratio (HR) 0.60 … Population: All Participants Time Point Measure Pharm: 5-ASA (3.0 g/d) Placebo 48 weeks N Analyzed … Population: All Participants Time Point Measure Pharm: 5-ASA (3.0 g/d) Placebo 48 weeks N Analyzed … Population: All Participants Time Point Measure Pharm: 5-ASA (3.0 g/d) Placebo 48 weeks N Analyzed

316. SRDR - Systematic Review Data Repository |
     srdr.ahrq.gov/projects/1565/studies/188640
     January 01, 2014 - No CPAP 82 months N Analyzed 441 268 … No CPAP 82 months N Analyzed 314 184 … No CPAP 82 months N Analyzed 127 84 … No CPAP 82 months N Analyzed 441 268 … No CPAP 82 months N Analyzed 441 268

317. App-D-Opioid-Chronic-Pain-Surveillance-Report-3 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-opioid-chronic-pain-surveillance-report-3.xlsx
     September 30, 2015 - Setting Country Eligibility Criteria Interventions Sample Characteristics Screened Eligible Randomized Analyzed … B Screened: 88 Eligible: 30 Randomized: 30 Analyzed: 27 A vs. … B Screened: 113 Eligible: 110 Randomized: 110 Analyzed: 110 (55 vs. 55) A vs. … B Screened: 1,669 Eligible: NR Randomized: 301 Analyzed: 293 A vs. … B Screened: 68 Eligible: 53 Randomized: 46 Analyzed: 40 (20 vs. 20) A vs.

318. App-D-Opioid-Chronic-Pain-Surveillance-Report-3 (xls file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/app-d-opioid-chronic-pain-surveillance-report-3.xlsx
     September 30, 2015 - Setting Country Eligibility Criteria Interventions Sample Characteristics Screened Eligible Randomized Analyzed … B Screened: 88 Eligible: 30 Randomized: 30 Analyzed: 27 A vs. … B Screened: 113 Eligible: 110 Randomized: 110 Analyzed: 110 (55 vs. 55) A vs. … B Screened: 1,669 Eligible: NR Randomized: 301 Analyzed: 293 A vs. … B Screened: 68 Eligible: 53 Randomized: 46 Analyzed: 40 (20 vs. 20) A vs.

319. Comparison of paired visual assessment and software analyses of changes in caries status over 6 months from fluorescence images | AHRQ Digital Healthcare Research: Informing Improvement in Care Quality, Safety, and Efficiency
     digital.ahrq.gov/health-it-tools-and-resources/health-it-costs-and-benefits-database/comparison-paired-visual
     January 01, 2007 - system where a fluorescent image of a tooth surface is captured using an intra-oral camera and then analyzed … system where a fluorescent image of a tooth surface is captured using an intra-oral camera and then analyzed

320. Automating detection of diagnostic error of infectious diseases using machine learning. | PSNet
     psnet.ahrq.gov/issue/automating-detection-diagnostic-error-infectious-diseases-using-machine-learning
     October 09, 2024 - More than 6.5 million ED visits were analyzed by the models and 130 were analyzed by expert physicians